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Abstract: The ability of bacteria to colonize catheters is a major cause of infection. In the cur-
rent study, catheters were surface-modified with MgF2 nanoparticles (NPs) using a sonochemical 
synthesis protocol described previously. The one-step synthesis and coating procedure yielded a 
homogenous MgF2 NP layer on both the inside and outside of the catheter, as analyzed by high 
resolution scanning electron microscopy and energy dispersive spectroscopy. The coating thick-
ness varied from approximately 750 nm to 1000 nm on the inner walls and from approximately 
450 nm to approximately 580 nm for the outer wall. The coating consisted of spherical MgF2 
NPs with an average diameter of approximately 25 nm. These MgF2 NP-modified catheters were 
investigated for their ability to restrict bacterial biofilm formation. Two bacterial strains most 
commonly associated with catheter infections, Escherichia coli and Staphylococcus aureus, were 
cultured in tryptic soy broth, artificial urine and human plasma on the modified catheters. The 
MgF2 NP-coated catheters were able to significantly reduce bacterial colonization for a period 
of 1 week compared to the uncoated control. Finally, the potential cytotoxicity of MgF2 NPs 
was also evaluated using human and mammalian cell lines and no significant reduction in the 
mitochondrial metabolism was observed. Taken together, our results indicate that the surface 
modification of catheters with MgF2 NPs can be effective in preventing bacterial colonization 
and can provide catheters with long-lasting self-sterilizing properties.
Keywords: MgF2 NP coating, modified surfaces, bacterial colonization, human plasma, artificial 
urine, biocompatibility
Introduction
Biomedical devices and implants are commonly used in the health care system. Over 
the past three decades, the number of artificial hip and knee implants has increased 
markedly, and stents, heart valves, vascular grafts, catheters, and other implanted devices 
have been used widely to save lives and to restore the quality of life to millions of people 
worldwide. Unfortunately, these abiotic surfaces are prone to bacterial colonization and 
device-related infections caused by bacterial attachment and proliferation.1–5
More than 200,000 nosocomial bloodstream infections occur each year in the 
USA and most of them are related to the use of intravascular devices.6,7 Central 
venous catheters are particularly prone to colonization.8,9 According to recent esti-
mates, 5% of the 7 million central venous catheters inserted annually are associated 
with catheter-related bloodstream infections.7,10 Chronic indwelling urinary catheters 
also increase the risk of infection, accounting for approximately 80% of all noso-
comial urinary tract infections.11,12 In an attempt to minimize the risk of infection 
associated with short-term biomedical devices, prophylactic measures are applied. 
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In addition, catheters are replaced at frequent intervals but 
such preventive replacement schedules impose considerable 
inconvenience to the patient and increase operation costs for 
the health care system.13
The current situation raises the urgent need to design 
surfaces that can restrict bacterial colonization and biofilm 
formation. One promising approach is to provide the surface 
with antimicrobial properties.14–17 A number of such devices 
have been developed18–21 and tested with variable success in 
clinical studies.9,10,12 However, the ideal catheter, a catheter 
that combines low-cost coating technology, a wide spectrum, 
and long-lasting antimicrobial properties, as well as safe 
utilization, has yet to be developed.
In this context, nanotechnology-driven approaches are 
expected to provide new opportunities for preventing and 
fighting biofilm-mediated infections via the extended use 
of atomic scale-tailored nanomaterials. The most interest-
ing and recent example uses silver-based compounds. The 
surface functionalization by silver nanoparticles (NPs) of 
polyurethane and plastic catheters was shown to have antibac-
terial/antibiofilm activity against a broad range of pathogenic 
strains (eg, Escherichia coli, Enterococci, Pseudomonas 
aeruginosa, and coagulase-negative Staphylococci).18,19,22 
However, since silver may also have cytotoxic effects, there 
is growing concern regarding the long-term exposure and use 
of silver-based nanomaterials.23–26 Thus, alternative nanoma-
terial compounds that can inhibit the bacterial colonization 
of catheter surfaces must be developed.
Our group has recently demonstrated the antibacterial 
and antibiofilm properties of highly crystalline, 25 nm-sized 
magnesium fluoride (MgF2) NPs using either a microwave or 
sonochemical chemistry for their synthesis.27,28   Antimicrobial 
activity of MgF2 NPs was highly dependent on the size of the 
NP.28 Our results revealed that the NPs penetrate the cells, 
reduce the internal pH, cause disruption to the membrane 
potential, and enhance lipid peroxidation.27,28 We also utilized 
this new metal-fluoride nanomaterial to coat glass slide cou-
pons and showed that the coated surfaces can restrict bacterial 
colonization and biofilm formation for up to 7 days.28 Results 
thus far suggest that the most active antibacterial nanomateri-
als exhibit an increased chemical surface-mediated reactivity, 
mainly due to their large surface-to-volume ratios and defined 
crystallographic structures.
The objective of the current study was to present a sono-
chemical method for depositing MgF2 NPs on latex-based 
catheters in a one-step process, and to obtain a long-lasting 
MgF2 NP coating on both sides of the catheter (namely, internal 
and external), even following exposure to various biological 
fluids (such as plasma and urine). The biocompatibility of 
MgF2 NP-coated catheters was also examined and preliminary 
results suggest that human cell lines are tolerant in contact 
with the MgF2 NP-coated latex. These findings provide a new 
approach for the future development of self-sterilizing catheter 
coatings based on magnesium fluoride NPs.
Materials and methods
Catheter-coating procedure  
and characterization
Latex-based Foley catheter (Unomedical, Birkerød,   Denmark) 
5 cm length segments were coated by   placing the catheter 
segments directly into the sonochemical   reaction medium 
according to the methodology described previously.28 In brief, 
magnesium (II) acetate tetrahydrate ([Mg(Ac)2 ⋅ (H2O)4], 99% 
purity; Sigma-Aldrich, St Louis, MO) and concentrated hydro-
fluoric acid (HF, 32% weight aqueous solution, ACS grade, 
BioLab, Albany, Auckland) were dissolved in double-distilled 
water (DDW; 100 mL) at a 1:2 equivalent ratio. The mixture 
(0.01 M HF) was irradiated with a high-intensity ultrasonic 
horn (Ti-horn [Sonics and Materials, Newton, CT], 20 kHz, 
750 W × cm−2, 60% power modulation) under argon (60 min-
utes, room temperature). The products were washed thor-
oughly with DDW (3 × 10 mL), absolute EtOH (2 × 10 mL), 
and dried in vacuum (10−2 mm Hg) in an inert glove box 
(O2 , 1 ppm). It should be emphasized that since catheters are 
soaked in the reaction medium the coating procedure simultane-
ously coats the external and internal sides of the catheter.
To verify the NP crystallinity, powder X-ray diffraction 
(XRD) measurements were carried out on a Bruker (Madison, 
WI) D8 diffractometer using Cu Kα radiation (λ = 1.5418 Å). 
Peak fitting and lattice parameter refinement were computed 
using the EVA software program (v 5.0; Bruker Analytical 
X-ray Systems). The NP morphology was characterized using 
a high-resolution scanning electron microscope (HR SEM; 
JEOL-6700F [JEOL, Tokyo, Japan], accelerating voltage 
15 kV) and a high-resolution transmission electron micro-
scope (HR TEM; JEOL-2010 HR TEM, accelerating voltage 
200 kV). NP samples for HR SEM analysis were chromium 
coated before imaging. NP samples for HR TEM analysis 
were prepared in absolute EtOH (ultrasonic dispersion), 
deposited onto a copper-coated grid (drop deposition), 
and then dried under vacuum (10−2 mmHg) before sample 
processing. The theoretical size and the size distribution of 
the NPs were calculated by the Debye–Scherrer equation 
and determined from the measurement (n = 200) of images 
taken with HR SEM, respectively. After completion of 
sonication, the sonochemically coated catheters were washed 
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with DDW (3 × 10 mL) followed by absolute EtOH (2 × 10 mL) 
and allowed to dry in vacuum (10−2 mmHg). Next, the samples 
were coated with chromium and imaged by HR SEM (JEOL-
6700F, accelerating voltage 15 kV).
To determine the amount of MgF2 NPs on the catheter sur-
faces, the outer circumference of the tubing (a layer of 0.1 cm) 
was removed using a sharp scalpel. The removed layer was 
soaked in 5 M of HNO3 and the magnesium concentration was 
then determined by inductively coupled plasma (ICP; ULTIMA 
2, Horiba Scientific, Edison, NJ). The dissolution in nitric 
acid (HNO3, ACS grade, BioLab) was repeated for the tubing 
remaining after the removal of the outer surface. This approach 
allowed us to measure the relative coating on the inner and 
outer surfaces. Uncoated catheter segments served as a negative 
control. To evaluate the coating distribution on the surface, we 
mapped the magnesium and fluorine elemental distributions on 
the inner and outer walls by energy dispersive X-ray analysis 
(EDS;EDAX, Mahwah, NJ) apparatus on SEM (FEI, Inspect™ 
S, Hillsboro, OR). Elemental mapping was performed at both 
15 keV and 0.58 nA with a resolution of 133 eV . Maps were 
created in most cases from 100 scan frames using a dwell time 
of 100 µs and 512 × 384 pixel/frame resolution.
Bacterial cultures and growth conditions
For static biofilm assays, Escherichia coli C600 (E. coli) and 
Staphylococcus aureus FRF119 (S. aureus) were grown in 
tryptic soy broth (TSB; Difco™, BD, Franklin Lakes, NJ) 
or tryptic soy broth 66% supplemented with 0.2% glucose 
(TSB-Glu)28 For the continuous culture flow model, E. coli 
and S. aureus were grown in TSB (pH = 7.6) or TSB-Glu 
(pH = 7.8, 10%) diluted in DDW (90%), respectively.29–31 
We also utilized human plasma (Magen David Adom Blood 
Bank, Shiba Hospital, Tel-Hashomer, Israel) for growth. In 
this case, fresh citrated (0.37% citrate) human plasma (67%) 
was diluted in TSB or TSB-Glu (33%) for E. coli and S. aureus 
growth, respectively. The plasma was diluted to 67% with 
TSB or TSB-Glu to enhance bacterial growth (pH = 7.4).32 
Finally, we also grew bacteria in artificial urine that was 
reconstructed using human urine proteins (Sigma-Aldrich) 
and salts, according to the manufacturer’s instructions. The 
pH of the reconstituted urine was adjusted to pH = 7.5. All 
experiments were incubated in aerobic conditions at 37°C.
MgF2 NP-coating stability
To determine the time-dependent stability of the MgF2 NP 
coating, the inner wall was tested using a continuous-flow 
model using the same bacterial media and growth conditions 
described above. Briefly, TSB, TSB-Glu, urine, or plasma 
was allowed to flow through the catheter at a rate of 10 mL 
per hour and aliquots from the flow-through were taken for 
analysis (see Antibiofilm assays). To examine the stability 
of the external coating, the catheter was incubated in the 
medium under static conditions (without any flow) and ali-
quots were taken at various time points for analysis.
Stability was characterized by determining the amount 
of NPs and/or Mg+2 released from the catheter surface. The 
samples taken were centrifuged for 30 minutes at 16,000 rela-
tive centrifugal force (centrifuge 5418,   Eppendorf, Harburg, 
Germany). The supernatant was analyzed by inductively 
coupled plasma ICP to determine the Mg+2 concentrations. 
To detect the potential presence of NPs, we removed the 
supernatant, washed it with DDW (3 × 10 mL), and treated it 
for 60 minutes with a solution of 10% (v/v) sodium dodecyl 
sulfate (Sigma-Aldrich) and 2% (v/v) β-mercaptoethanol 
in water to denature the potential proteins present on the 
NP surface. The proteins were removed from the solution 
using NaCl (3 M) solution and re-suspended in ethanol 
(ACS grade, BioLab) for dynamic light scattering (DLS; 
N-4 particle size analyzer, Beckman Coulter Inc, Brea, CA), 
NP-measurements, and TEM imaging.
Antibiofilm assays
We evaluated the antibiofilm properties of the two sides of 
the coated catheter (the external and internal walls).
The external wall was assayed using a static biofilm assay. 
The 5 cm catheter segments were placed in a six-well plate 
(Greiner Bio One, Frickenhausen, Germany). Each well 
contained a 5 mL bacterial suspension of either E. coli or S. 
aureus at a final concentration of approximately 3 × 108 colony 
forming units (CFU)/mL solution in the appropriate growth 
media. After 1, 3, and 7 days of incubation, the undesired S. 
aureus and E. coli biofilm cells grown in the inside wall were 
fixed with glutaraldehyde and paraformaldehyde for 1 hour. 
The outside wall biofilm cells were detached by exposure to 
low energy sonication water bath (TRANSSONIC 460, Elma, 
Singen, Germany) for 1 minute and centrifuged at 2150 g for 
5 minutes to form a pellet of cells. A viable count was deter-
mined by resuspending the cells in media and plating serial 
dilutions on Luria Bertani (Difco).
The inside wall was assayed by a continuous culture 
flow model. A 5 cm catheter segment was inoculated 
with approximately 3 × 108 CFU/mL of an E. coli and 
S. aureus culture. The flow (in the indicated media) was 
initiated after 1 hour with a flow rate of 10 mL per hour. 
The system was incubated at 37°C for 7 days and the biofilm 
was extracted from the catheter as described previously.33,34 
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The cells were diluted in 1% Luria-Bertani and plated for 
viable counting. The relative reduction in colonization, 
N/N0, was determined by calculating the CFU per mL of 
the culture. The terms N0 and N stand for the numbers of 
CFU present on uncoated and MgF2 NP-coated catheters, 
respectively. An alternative approach to determine the bio-
film biomass crystal violet (CV) staining was also utilized. 
Briefly, catheter segments (the external and internal walls) 
were washed twice with DDW to remove non attached cells 
and stained with 1% CV (Sigma-Aldrich) for 15 minutes 
at room temperature. Stained wells were then washed five 
times with DDW and the remaining CV was eluted by the 
addition of absolute ethanol for 15 minutes. The biofilm 
biomass was then determined by measuring the absorbance 
at OD595. Data were analyzed by analysis of variance and 
results were considered to be significant at P , 0.05.
Cell culture and cytotoxicity assay
HeLa, human embryonic kidney 293 (HEK 293), and 
mouse embryonic fibroblasts (MEFs) cell lines were cul-
tured in petri dishes in Dulbecco’s Minimum Essential 
Medium (Gibco® DMEM, Life Technologies Corp, Grand 
Island, NY) supplemented with 10% fetal calf serum, 1% 
penicillin/streptomycin, and 1% glutamine. The cells were 
seeded at a density of 10,000 cells per well in 24-well tis-
sue culture plates (Greiner), which contained MgF2-coated 
and uncoated latex-based catheter segments. The cells were 
incubated at 37°C in a humidified atmosphere of 5% CO2 
for 24 hours. Following incubation, the catheter segments 
(with attached cells) were removed for further analysis, as 
described below.
For microscopy imaging, the HeLa cells that were grown 
on the catheters were fixed in 4% paraformaldehyde for 
30 minutes, washed in phosphate-buffered saline, and then 
blocked with 20% fetal bovine serum/0.5%Triton X-100 
(Sigma-Aldrich) in phosphate-buffered saline for 1 hour 
and incubated overnight with a primary antibody (β-tubulin 
monoclonal antibody; Developmental Studies Hybridoma 
Bank, Iowa City, IA) at 4°C. After washing, the catheters 
were incubated with a rhodamine-conjugated anti-mouse 
secondary antibody at 1:150 dilution (Jackson Immuno 
Research Laboratories Inc, West Grove, PA). The DNA was 
visualized with 4′,6-diamidino-2-phenylindole stain (Sigma-
Aldrich) and the catheters were mounted on slides with the 
VECTASHIELD® mounting solution (Vector Laboratories 
Inc, Burlingame, CA) and sealed. Imaging was obtained 
from an ApoTome microscope (Axio Imager, Carl Zeiss 
MicroImaging GmbH, Jena, Germany).
The cells were also analyzed for cell viability using 
a colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) assay, as described by 
Mosmann.35 The assay is based on the ability of meta-
bolically active cells to reduce MTT, a yellow tetrazolium 
salt, to a purple formazan. In brief, following 24 hours of 
incubation, 100 µL of a MTT (5 mg/mL) labeling mixture 
was added to each well and the microplate was incubated 
for 15–45 minutes. After incubation, the MTT-containing 
medium was removed from the microplate and the insoluble 
formazan dissolved in 50 µL of dimethyl sulfoxide. Cell 
viability was determined by measuring the absorbance at 
OD570 using a microplate reader (Synergy™ 2, BioTek 
Instruments Inc, Winooski, VT).
Results and discussion
MgF2 NP catheter-coating procedure  
and characterization
Sonochemistry has been shown to effectively coat various flat 
surfaces, including rigid and soft polymers.17,36,37 However, 
this one-step synthesis and coating procedure was never 
applied for coating more structurally complex surfaces such 
as tubes in which both the internal and external sides need to 
be coated. However, as the synthesis and coating procedure 
is obtained in the same reaction chamber, we reasoned that 
as the solution will penetrate the inside of the catheter, this 
will also simultaneously allow the coating of the internal 
part. As described in the experimental procedure, catheters 
were coated by adding segments directly into the chemi-
cal reaction medium, using the same reaction parameters 
described for the synthesis of the NPs (see Figure S1). In the 
sonochemical synthesis, stable MgF2 NP coatings are formed 
by the high energy created by the collapse of the cavitation 
bubbles.38 This collapse creates very high temperatures and 
pressure, conditions leading to the rupture of chemical bonds 
(Figure 1).38,39 According to the interpretation suggested for 
the sonochemical coating process, microjets are formed 
after the collapse of the acoustic bubble near a solid surface 
(Figure 1). These microjets throw the newly formed NPs at 
the solid substrate at such a high speed (.200 m/second) 
that the NPs could penetrate surfaces to a depth of up to 
90 nm.28,38,40
Our initial characterization measurements were aimed at 
determining the shape and the size of the MgF2 NPs formed 
in the sonochemical reaction. The MgF2 NP-coated catheters 
were imaged by HR SEM (Figure 2). The catheter surfaces 
were completely covered, with spherical NPs having an 
average size of approximately 25 nm (Figure 2). The size 
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during the synthesis confirms this fact, and the amount of 
NPs deposited varies from 0.021 (±0.003) to 0.010 (±0.005) 
mg/cm2 for the inside and outside walls, respectively. We 
also evaluated the homogeneity of the coating deposition by 
elemental mapping analysis of magnesium and fluorine using 
EDS. Figure 3 shows the distribution of the MgF2 NP coating 
on the two walls. MgF2 NP-coated catheters present a large 
and homogeneous distribution of the signals emitted from 
magnesium and fluorine detection. We have also scanned the 
uncoated catheter for Mg and F, and while a very low magne-
sium signal was detected, fluorine could not be found on the 
uncoated segments. This can most likely be explained by the 
fact that the magnesium we detected comes from traces of 
surfactants or residues in the water used during the catheter 
fabrication processing.41
As described above, we did observe a difference in the 
coating between the external and internal surfaces. Relating 
to the weight quantification of the MgF2 NP coating and the 
HR SEM imaging, we also detected a higher fluorescence 
emission signal of magnesium and fluorine from the inner 
Figure 1 General view of the MgF2 NPs synthesis and NPs deposition on catheter 
walls by sonochemistry. MgF2 (black spheres) formation under ultrasonic irradiation 
(red waves). Microjets (blue arrows) were formed after the collapse of the acoustic 
bubble near the catheter wall and throw the NPs to create MgF2 NP-coating.
Abbreviation: NPs, nanoparticles.
Microjets
Sonocavitation
Horn
Catheter wall
H2O
H2O
H2O
H2O
Mg+2
Mg+2
H2O
F−
F−
F−
F−
and the morphology are similar to the data measured by HR 
TEM and XRD for the suspended NPs (formed under similar 
reaction conditions, but without the catheters in the reaction 
vessel: see Figure S1).
The side view of the MgF2 NP-coated catheter revealed 
coatings on both the external and internal walls of the 
catheter. The coating thickness varied from approximately 
750 to approximately 1000 nm on the inner walls and from 
approximately 450 to approximately 580 nm for the outer 
wall (Figure 2). The quantification of the MgF2 NPs deposited 
Figure 2 Imaging of sonochemical MgF2 NP catheter coating. Catheters were coated 
using a sonochemical procedure described in the experimental section. hR SEM 
images of the lateral sections of the internal and external walls of uncoated and MgF2 
NP-coated catheters are presented. Inserts provide an enlarged view of the coating 
showing the typical spherical MgF2 NP structure.
Note: Black arrows indicate the thickness of the MgF2 NP coating.
Abbreviations:  hR  SEM,  high  resolution  scanning  electron  microscope;   
NP, nanoparticle.
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Figure  3  Distribution  of  the  MgF2  NP  coating  on  the  catheter’s  surface. 
Elemental mapping analysis of magnesium (red) and fluor (purple). The signals 
were detected from the internal and external sides of coated and uncoated 
catheters with MgF2 NPs.
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wall compared to that obtained from the external wall 
 ( Figure 3). One of the possible explanations for this phe-
nomenon could be in the surface topography. The creation 
of acoustic bubbles is supported by the roughness of the 
surface.38 A rougher internal surface of the catheter helps 
in the separation of the water molecules, thus forming the 
acoustic cavity. Furthermore, as more bubbles are created and 
collapse inside the catheter, an increase in the deposition of 
MgF2 NPs on the internal wall is expected.
Stability of the MgF2 NP coating
To examine the stability of the coating, we began by   exposing 
the MgF2 NP-coated catheters to growth media (without 
  bacteria). The coating stability of both the external and inter-
nal sides were examined under static and flow   conditions. To 
exclude the possibility of NPs leaching from the catheter sur-
faces, we conducted DLS measurements and TEM imaging 
of the biological medium following contact with the inside 
and outside catheter walls at regular time points during the 
experiment. No MgF2 NP leaching was detected from the 
native surface during the entire 7 days (data not shown). This 
observation is reinforced by HR SEM imaging (Figure 4) that 
revealed stable MgF2 NP coating on the inside and outside 
walls, even following the 7-day exposure. The coated catheter 
surface remained intact and the MgF2 NP coating was still 
homogenous (Figure 4). It should be emphasized that an 
organic coating, probably composed mainly of proteins, was 
observed on the catheter walls exposed to urine and plasma, 
due to the attachment of proteins present in high concentra-
tions in urine and plasma (Figure 4). Taken together, these 
results confirm that the sonochemical technique can provide 
a stable MgF2 NP coating on latex catheter surfaces.
The release of Mg+2 ions from the coatings was also 
measured by ICP analysis. Figure 5 depicts the concentration 
measurements of Mg+2 released from the external (Figure 5A) 
and internal (Figure 5B) sides during exposure to TSB/
TSB-Glu, artificial urine, and plasma. The amounts of Mg+2 
detected were at the nM levels (Figure 5). Furthermore, the 
levels of Mg+2 reached a steady state after approximately 
24 hours and remained constant for the next 7 days in all 
the tested media.
It is interesting to note that we observed a difference in the 
amounts of Mg+2 released from the external (Figure 5A) and 
internal walls (Figure 5B). The Mg+2 concentrations released 
from the external wall were two-fold higher than those found 
in the internal wall. The lower Mg+2 concentration measured 
from coating exposed to plasma and TSB varied from approxi-
mately 4.74 nM (plasma) to 7.46 nM (TSB) and from 8.40 nM 
(plasma) to 14.27 nM (TSB) for the internal and external walls, 
respectively (Figure 5A and B). The concentration of Mg+2 
released from catheters exposed to urine varied from 7.30 nM 
to 9.63 nM for the internal and external walls, respectively. One 
possible explanation for these differences can be attributed to 
the difference in the continuous flow and static models tested 
and their influence on the steady-state dissolution of MgF2 
NPs. Future work will be required to understand the exact phe-
nomenon. In addition, we observed a difference in the release 
of Mg+2 when MgF2 NP coatings were exposed to different 
biological fluids. When exposed to urine and plasma, both 
walls displayed significantly less MgF2 dissolution compared 
to TSB and TSB-Glu. This decrease may be attributed to the 
attachment of proteins present in high concentrations in urine 
and plasma, which provide a “protective barrier” against the 
mechanical frictions between the medium and the catheter, and 
prevent the detachment of the external layer of the coating. 
It should be emphasized that this conditioning film may also 
affect the antimicrobial activity of the coating (see Antibio-
film properties of MgF2 NP-coated catheters).
Figure 4 Catheter surface topography after incubation with biological fluids. HR SEM images of the inside and outside walls of MgF2 NP-coated catheters after 7 days 
exposure in TSB, TSB-Glu, urine, and plasma, as described in the experimental section.
Abbreviations: Glu, glucose; hR SEM, high resolution scanning electron microscope; NP, nanoparticle; TSB, tryptic soy broth.
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Antibiofilm properties of MgF2 NP-
coated catheters
In a previous study, we showed that MgF2 NP coating effec-
tively inhibited the bacterial adhesion and biofilm formation 
of two common biofilm-forming pathogens, S. aureus (Gram-
positive) and E. coli (Gram-negative) for 7 days, as compared 
to the uncoated control.28 Considering these encouraging 
results, the effectiveness of MgF2 NP-coated catheters to 
inhibit bacterial colonization was further examined.
First, we tested the antibiofilm activity using standard 
growth media, (TSB and TSB-Glu for E. coli and S. aureus, 
respectively) biofilms were grown for 7 days and biofilm bio-
mass was determined by either viable counts or CV staining 
(Tables 1 and 2). The coating on both the internal and external 
walls resulted in a 100% decrease in biofilm formation for 
both E. coli and S. aureus after 24 hours, compared to the 
uncoated surface (Tables 1 and 2). Differences in reduction 
between the bacterial species and between the internal and 
external walls were seen to start at day 3 and continued until 
day 7. By day 7, a 43% reduction in E. coli biofilm viability on 
the outside wall, and a 65% reduction in the inside wall, were 
still observed (Table 1). S. aureus showed more promising 
results, with a 66% reduction in biofilm viability on the outside 
wall and a 79% decrease in the inside wall (Table 2).
Next, we examined the impact of biological fluids on 
the antibiofilm activity of these coated catheters. Urine is 
Figure 5 Amount of Mg+2 released over time from MgF2 NP-coated catheters. Coated catheters were incubated for 7 days in various fluids (TSB, TSB-Glu, urine and plasma) 
as described in the experimental section. The Mg+2 released from the coating of the (A) external wall and the (B) internal wall are presented. The Mg+2 concentration released 
following the incubation was determined by the difference in the Mg+2 concentration present in normal levels in TSB, TSB-Glu, urine, plasma and the concentrations measured 
at each time point.
Note: Data represent the mean ± SD values of three independent experiments conducted in triplicate.
Abbreviations: Glu, glucose; NP, nanoparticle; SD, standard deviation; TSB, tryptic soy broth.
5
10
15
20
B
A
2
2
01
0
Time (days)
M
g
+
2
 
(
n
M
)
M
g
+
2
 
(
n
M
)
34
4
56
6
8
10
7
2 0
0
1
Time (days)
3 4 567
Plasma
Urine
TSB
TSB-Glu
Plasma
Urine
TSB
TSB-Glu
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1181
Antibiofilm surface functionalization of cathetersInternational Journal of Nanomedicine 2012:7
known to contain an assortment of inorganic salts and organic 
compounds, including proteins, hormones, and a wide range 
of metabolites. In theory, a reduction of the antibiofilm 
properties would be expected, mainly due to the production 
of a conditioning film, but the MgF2 NP-coated catheters 
maintained fairly high antibiofilm properties. Interestingly, the 
biofilm development of E. coli and S. aureus in urine was still 
reduced by 100% in 24 hours on both the inside and outside 
walls (Tables 1 and 2). The coating maintained its antibiofilm 
activity even after 7 days. S. aureus displayed a 56% reduc-
tion in viability on the outside wall and 52% reduction on the 
inside wall, compared to the uncoated samples (Table 2), while 
E. coli biofilm viability was reduced by 45% and 54% on the 
outside and inside walls, respectively (Table 1).
We then examined the antibiofilm activity of the coated 
catheters exposed to plasma. Plasma is very rich in circulating 
plasma proteins, including immunoglobulins, complement 
proteins, fibronectin, and more.42 As described above, these 
proteins associated with dead cells may provide a condition-
ing film that may reduce the antibiofilm activity by providing 
a protective barrier between the surface and the bacteria. 
Interestingly, the coated catheters were still able to reduce 
the ability of bacteria to colonize the catheter surface. After 
24 hours, E. coli biofilm viability on the outside wall was 
reduced by 84% and by 85% on the inside wall, compared 
to the non-coated samples. S. aureus biofilm viability was 
reduced by 76% on both the inside and outside walls after 
24 hours. On day 7, the reduction on the outside wall of both 
E. coli and S. aureus biofilm viability was approximately 
16%, and the inside wall showed a reduction of approxi-
mately 20% in both bacteria.
As stated above we also utilized crystal violet staining to 
quantify the biofilm biomass that developed on coated and 
uncoated catheters. As seen in Tables 1 and 2, a similar trend 
was observed under all tested conditions and the results cor-
relate nicely with the viable cell counts (Tables 1 and 2).
To exclude the possibility that magnesium or fluorine 
ions released from the catheter walls are responsible for the 
antibiofilm activity observed, the following control experi-
ments were conducted. We dissolved separately two magne-
sium and fluoride acetate precursor salts in water to obtain a 
Mg+2(aq) or F−(aq) concentration, which is a 100 times higher 
Table 1 Antibiofilm properties of the catheter walls coated with MgF2 NP against Escherichia coli biofilm formation
Media Time (days) Viable count Biofilm biomass
MgF2NP coating N/N0 Reduction   
(%)
Uncoated  
(OD595/cm2)
MgF2 NP coating   
(OD595/cm2)
Reduction   
(%)
Outside wall
TSB 1 2.1 (±0.12) × 103 1.4 (±0.08) × 10−6 ∼100 0.465 (±0.18) 0.002 (±0.00) ∼100
3 3.9 (±0.03) × 109 1.3 (±0.05) × 10−2 86 0.671 (±0.11) 0.62 (±0.12) 46
7 3.2 (±0.01) × 1010 5.2 (±0.01) × 10−2 43 0.832 (±0.14) 0.536 (±0.08) 20
Urine 1 3.8 (±0.15) × 102 7.4 (±0.11) × 10−5 ∼100 0.243 (±0.09) 0.004 (±0.00) ∼100
3 1.5 (±0.08) × 107 3.1 (±0.03) × 10−2 68 0.356 (±0.14) 0.213 (±0.08) 40
7 1.0 (±0.01) × 109 5.2 (±0.12) × 10−2 45 0.447 (±0.17) 0.348 (±0.11) 22
Plasma 1 1.0 (±0.03) × 104 1.6 (±0.02) × 10−2 84 0.108 (±0.14) 0.001 (±0.00) ∼100
3 1.1 (±0.05) × 105 6.4 (±0.22) × 10−2 31 0.223 (±0.08) 0.171(±0.15) 23
7 5.8 (±0.02) × 106 8.4 (±0.11) × 10−2 15 0.299 (±0.20) 0.269 (±0.12) 10
Inside wall
TSB 1 6.1 (±0.01) × 102 4.6 (±0.02) × 10−5 ∼100 0.422 (±0.08) 0.002 (±0.04) ∼100
3 3.1 (±0.03) × 108 5.0 (±0.13) × 10−3 95 0.543 (±0.15) 0.260 (±0.14) 52
7 1.0 (±0.18) × 1010 3.2 (±0.09) × 10−2 65 0.654 (±0.11) 0.601 (±0.10) 18
Urine 1 4.3 (±0.04) × 102 3.5 (±0.02) × 10−4 ∼100 0.265 (±0.13) 0.001 (±0.00) ∼100
3 2.5 (±0.08) × 106 1.1 (±0.17) × 10−2 88 0.376 (±0.08) 0.203 (±0.08) 46
7 5.9 (±0.03) × 107 4.5 (±0.05) × 10−2 54 0.321 (±0.07) 0.256 (±0.17) 20
Plasma 1 2.4 (±0.04) × 104 1.1 (±0.03) × 10−2 85 0.098 (±0.04) 0.002 (±0.00) ∼100
3 1.6 (±0.02) × 106 5.5 (±0.12) × 10−2 43 0.154 (±0.13) 0.143 (±0.11) 17
7 6.2 (±0.05) × 106 7.5 (±0.11) × 10−2 24 0.222 (±0.16) 0.202 (±0.05) 9
Notes: Biofilm biomass quantification and viable count of the biofilm cells of E. coli grown in TSB, urine, and plasma. The outside and inside walls of MgF2 NP-coated catheter 
incubated for 7 days at 37°C. Uncoated catheters served as the negative control and N/N0 is the relative reduction in biofilm viability fraction. Values in parentheses represent 
the standard deviation of three independent experiments conducted in triplicates. The results were found to be statistically significant (P , 0.05) between MgF2 NP-coated 
versus uncoated catheters in all treatments.
Abbreviations: NP, nanoparticle; TSB, tryptic soy broth.
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than the expected concentration of these ions based on the 
solubility of MgF2 in water. The results show that even at 
these higher concentrations, the ions are not able to cause a 
similar inhibition in biofilm formation (Tables S1 and S2). 
Taken together, these results strongly suggest that the nano-
metric properties of MgF2 are responsible for the antibiofilm 
activity, and not the dissolved ions. This is also supported 
by our previous work.27
Biocompatibility of MgF2 NP-coated 
catheters
The potential use of NPs in various medical applications raises 
the need to examine the potential cytotoxicity effect of these 
agents. Despite the rapid progress of nanotechnology, the 
potential of adverse health affects due to prolonged exposure 
to nanomaterials has yet to be thoroughly   investigated. Silver 
NPs, for example, have gained much popularity recently 
owing to their broad-spectrum antimicrobial activity.24,43,44 
However, recent in vivo reports have established that expo-
sure to silver NPs may induce severe side effects, including 
changes in lung function; increase in inflammation; and 
activation of a mitochondria-dependent, stress-activated 
protein kinase pathway.45 In addition, the induction of distinct 
developmental defects in zebrafish embryos has been reported 
in response to exposure to silver NPs.46 To begin to evaluate the 
potential or MgF2 NPs-coated catheters to exert cytotoxicity, 
we conducted MTT viability measurements on HeLa, HEK 
293, and MEFs cell lines exposed to coated and uncoated 
catheters (Table 3). In HeLa cells less than 20% reduction 
in the mitochondrial activity was observed upon exposure to 
MgF2 NP-coated catheters, compared to the mitochondrial 
activity of cells grown on uncoated catheters (Table 3). The 
same trend was also observed with the HEK 293 and MEFs 
cell lines and no significant reduction was measured (from 
15% to 5% for MEFs and HEK 293, respectively).
We confirmed these results by fluorescence microscopy 
using HeLa cells. As depicted in Figure 6, no changes in cell 
morphology, size and membrane symmetry were observed 
in cells grown on MgF2 NP-coated surfaces. In addition, no 
sign of apoptosis such as the appearance of apoptotic bodies 
was observed. Furthermore, fluorescent microscopy was used 
to evaluate a potential process of programmed cell death; 
Table 2 Antibiofilm properties of the catheter walls coated with MgF2 NP against Staphyloccocus aureus biofilm formation
Media Time (days) Viable count Biofilm biomass
MgF2 NP coating N/N0 Reduction   
(%)
Uncoated  
(OD595/cm2)
MgF2 NP coating   
(OD595/cm2)
Reduction 
(%)
Outside wall
TSB-Glu 1 2.1 (±0.12) × 103 1.4 (±0.08) × 10−6 ∼100 0.132 (±0.10) 0.001 (±0.00) ∼100
3 3.9 (±0.03) × 109 1.3 (±0.05) × 10−2 86 0.343 (±0.12) 0.113 (±0.05) 67
7 3.2 (±0.01) × 1010 5.2 (±0.01) × 10−2 43 0.512 (±0.02) 0.343 (±0.11) 33
Urine 1 3.8 (±0.15) × 102 7.4 (±0.11) × 10−5 ∼100 0.143 (±0.13) 0.001 (±0.00) ∼100
3 1.5 (±0.08) × 107 3.1 (±0.03) × 10−2 68 0.288 (±0.09) 0.095 (±0.13) 67
7 1.0 (±0.01) × 109 5.2 (±0.12) × 10−2 45 0.443 (±0.15) 0.349 (±0.09) 21
Plasma 1 1.0 (±0.03) × 104 1.6 (±0.02) × 10−2 84 0.092 (±0.13) 0.002 (±0.03) ∼100
3 1.1 (±0.05) × 105 6.4 (±0.22) × 10−2 31 0.155 (±0.11) 0.008 (±0.11) 43
7 5.8 (±0.02) × 106 8.4 (±0.11) × 10−2 15 0.221 (±0.05) 0.201 (±0.08) 19
Inside wall
TSB-Glu 1 6.1 (±0.01) × 102 4.6 (±0.02) × 10−5 ∼100 0.154 (±0.14) 0.003 (±0.01) ∼100
3 3.1 (±0.03) × 108 5.0 (±0.13) × 10−3 95 0.388 (±0.02) 0.135 (±0.11) 65
7 1.0 (±0.18) × 1010 3.2 (±0.09) × 10−2 65 0.587 (±0.08) 0.369 (±0.13) 37
Urine 1 4.3 (±0.04) × 102 3.5 (±0.02) × 10−4 ∼100 0.154 (±0.16) 0.000 (±0.00) ∼100
3 2.5 (±0.08) × 106 1.1 (±0.17) × 10−2 88 0.308 (±0.05) 0.095 (±0.10) 69
7 5.9 (±0.03) × 107 4.5 (±0.05) × 10−2 54 0.455 (±0.13) 0.236 (±0.14) 48
Plasma 1 2.4 (±0.04) × 104 1.1 (±0.03) × 10−2 85 0.087 (±0.14) 0.001 (±0.02) ∼100
3 1.6 (±0.02) × 106 5.5 (±0.12) × 10−2 43 0.134 (±0.01) 0.088 (±0.12) 34
7 6.2 (±0.05) × 106 7.5 (±0.11) × 10−2 24 0.265 (±0.15) 0.212 (±0.11) 20
Notes: Biofilm biomass quantification and viable count of the biofilm cells of S. aureus grown in TSB-Glu, urine, and plasma. The outside and inside walls of MgF2 NP-coated 
catheter incubated for 7 days at 37°C. Uncoated catheters served as the negative control and N/N0 is the relative reduction in biofilm viability fraction. Values in parentheses 
represent the standard deviation of three independent experiments conducted in triplicates. The results were found to be statistically significant (P , 0.05) between MgF2 
NP-coated versus uncoated catheters in all treatments.
Abbreviations: Glu, glucose; NP, nanoparticle; TSB, tryptic soy broth.
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β-tubulin staining showed that the cytoskeleton of cells grown 
on MgF2 NP-coated catheters had the same phenotype as the 
control cells grown on uncoated catheters (Figure 6). DNA 
staining was also conducted and no nuclear fragmentation, 
chromatin condensation, or chromosomal DNA fragmentations 
were observed (Figure 6). Taken together, these preliminary 
results support further testing of the tolerance and cytotoxicity 
of the MgF2 NP-coated surfaces, and emphasize the potential 
of using these NPs for various medical applications.
Conclusion
The present study presents the synthesis and coating of crys-
talline MgF2 NP on catheters using a simple sonochemical 
process. Our results revealed that this ultrasonic synthesis 
provides a stable and antibiofilm active coating. The MgF2 
NP coating is homogenous and is present on both the inter-
nal and external sides of the catheter. The coated catheters 
effectively restricted biofilm formation in both growth media 
and biologically relevant fluids (human plasma and urine). In 
addition, the preliminary biocompatibility assays suggest no 
major adverse effects on human cell lines. Taken together, the 
results of this study emphasize the potential use of MgF2 NPs 
as a new approach for the design of sterile surface coatings 
that may be useful for various medical applications.
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Supplementary data
MgF2 NP characterization
The NP morphology and its crystalline characterization are 
depicted in Figure S1. The powder XRD analysis of the NPs 
showed a clear crystalline pattern (Figure S1A). The XRD 
pattern matched the reflection peaks of the tetragonal MgF2 
phase (Joint Committee on Powder Diffraction Standards card 
No 00-041-1443) characterized by diffraction planes (110), 
(101), (111), (210), (211), (220), (002), (310), (301), (311), 
and (222). No additional diffraction peaks of any impurity 
were detected, demonstrating the high purity of the product. 
In addition, the average diameter of crystallites calculated by 
the Debye–Scherrer equation afforded a value of 24.8 nm, 
which is similar to the average size measured by HR SEM 
(Figure S1B and C). The fabricated MgF2 NPs showed 
spherical, well-shaped nanostructure morphology. Figure S1D 
also disclosed characteristic lattice fringes of the crystalline 
phase. The measured inter-fringe distance of 3.32 Å matches 
perfectly the (110) interplanar distance (Joint Committee on 
Powder Diffraction Standards card No 00-041-1443).
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Figure S1 MgF2 NP characterization. (A) XRD patterns of MgF2 NPs with the Miller indices of the respective atomic planes; (B) hR SEM image; (C) size distribution; and 
(D) hR TEM micrograph of MgF2 NPs and the 110 plane.
Abbreviations: hR SEM, high resolution scanning electron microscope; hR TEM, high resolution transmission electron microscope; NP, nanoparticle; XRD, X-ray 
diffraction.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1186
Lellouche et alInternational Journal of Nanomedicine 2012:7
Table S1 Influence of Mg+2 and F− on the Escherichia coli biofilm formation on the catheter walls
Media Time (days) Biofilm biomass Viable count
Medium only   
(OD595/cm2)
+Mg+2  
(OD595/cm2)
+F-  
(OD595/cm2)
Medium only  
(CFU/cm2)
+Mg+2  
(CFU/cm2)
+F-  
(CFU/cm2)
Outside wall
TSB 1 0.465 (±0.18) 0.476 (±0.08) 0.454 (±0.11) 6.2 (±0.11) × 108 4.1 (±0.09) × 109 2.5 (±0.11) × 108
3 0.671 (±0.11) 0.643 (±0.16) 0.635 (±0.06) 3.6 (±0.27) × 1010 2.6 (±0.13) × 1010 3.5 (±0.27) × 109
7 0.832 (±0.14) 0.844 (±0.11) 0.854 (±0.13) 5.9 (±0.03) × 1010 4.5 (±0.26) × 1011 1.2 (±0.03) × 1010
Urine 1 0.243 (±0.09) 0.256 (±0.19) 0.244 (±0.09) 5.2 (±0.12) × 106 3.6 (±0.42) × 106 4.0 (±0.12) × 106
3 0.356 (±0.14) 0.387 (±0.10) 0.396 (±0.13) 6.0 (±0.08) × 108 7.0 (±0.08) × 109 7.2 (±0.08) × 108
7 0.447 (±0.17) 0.466 (±0.07) 0.470 (±0.17) 3.1 (±0.02) × 109 1.1 (±0.11) × 109 2.0 (±0.02) × 1010
Plasma 1 0.108 (±0.14) 0.143 (±0.04) 0.145 (±0.02) 6.0 (±0.33) × 104 2.5 (±0.07) × 104 1.8 (±0.33) × 104
3 0.223 (±0.08) 0.203 (±0.04) 0.233 (±0.14) 1.7 (±0.32) × 104 1.4 (±0.16) × 107 1.94 (±0.32) × 106
7 0.299 (±0.20) 0.303 (±0.10) 0.313 (±0.11) 6.9 (±0.52) × 106 3.6 (±0.32) × 106 2.5 (±0.52) × 106
Inside wall
TSB 1 0.422 (±0.08) 0.413 (±0.10) 0.431 (±0.11) 2.8 (±0.11) × 107 1.0 (±0.14) × 107 2.1 (±0.24) × 106
3 0.543 (±0.15) 0.555 (±0.11) 0.548 (±0.12) 4.1 (±0.02) × 109 2.0 (±0.32) × 109 5.2 (±0.53) × 109
7 0.654 (±0.11) 0.663 (±0.01) 0.655 (±0.12) 5.3 (±0.41) × 1010 1.3 (±0.17) × 1011 7.8 (±0.23) × 1010
Urine 1 0.265 (±0.13) 0.276 (±0.12) 0.231 (±0.13) 1.2 (±0.12) × 106 3.6 (±0.12) × 106 5.6 (±0.36) × 106
3 0.376 (±0.08) 0.306 (±0.03) 0.346 (±0.13) 5.6 (±0.22) × 108 7.2 (±0.18) × 108 3.8 (±0.77) × 107
7 0.321 (±0.07) 0.333 (±0.17) 0.357 (±0.14) 7.8 (±0.36) × 108 5.2 (±0.44) × 108 4.7 (±0.02) × 108
Plasma 1 0.098 (±0.04) 0.100 (±0.05) 0.111 (±0.13) 3.6 (±0.21) × 104 4.1 (±0.51) × 104 3.6 (±0.21) × 104
3 0.154 (±0.13) 0.145 (±0.11) 0.134 (±0.01) 4.2 (±0.17) × 106 3.8 (±0.33) × 106 8.8 (±0.47) × 106
7 0.222 (±0.16) 0.215 (±0.06) 0.217 (±0.12) 1.2 (±0.22) × 106 4.8 (±0.05) × 107 9.8 (±0.21) × 106
Notes: Biofilm biomass quantification and viable count of the biofilm cells of E. coli grown in TSB, urine, and plasma on a catheter exposed to fluorine (0.5 mg/mL), and magnesium 
ions (0.5 mg/mL). Catheters incubated for 7 days at 37°C. Values in parentheses represent the standard deviation of three independent experiments conducted in triplicates.
Abbreviation: TSB, tryptic soy broth.
Table S2 Influence of Mg+2 and F− on the Staphylococcus aureus biofilm formation on the catheter walls
Media Time (days) Biofilm biomass Viable count
Medium only   
(OD595/cm2)
+Mg+2  
(OD595/cm2)
+F-  
(OD595/cm2)
Medium only  
(CFU/cm2)
+Mg+2  
(CFU/cm2)
+F-  
(CFU/cm2)
Outside wall
TSB-Glu 1 0.132 (±0.10) 0.137 (±0.11) 0.126 (±0.10) 3.2 (±0.01) × 108 1.7 (±0.17) × 108 6.3 (±0.07) × 108
3 0.343 (±0.12) 0.363 (±0.02) 0.345 (±0.03) 5.8 (±0.06) × 109 3.6 (±0.28) × 109 7.8 (±0.22) × 109
7 0.512 (±0.02) 0.545 (±0.04) 0.538 (±0.14) 6.3 (±0.54) × 1011 4.8 (±0.36) × 1010 1.5 (±0.48) × 1010
Urine 1 0.143 (±0.13) 0.133 (±0.17) 0.154 (±0.11) 8.3 (±0.41) × 106 6.2 (±0.05) × 106 3.2 (±0.08) × 106
3 0.288 (±0.09) 0.256 (±0.11) 0.276 (±0.13) 9.1 (±0.36) × 107 7.1 (±0.16) × 107 4.2 (±0.63) × 108
7 0.443 (±0.15) 0.448 (±0.12) 0.421 (±0.12) 5.6 (±0.74) × 109 7.1 (±0.25) × 1010 3.8 (±0.23) × 1010
Plasma 1 0.092 (±0.13) 0.100 (±0.11) 0.099 (±0.01) 2.6 (±0.25) × 104 2.5 (±0.36) × 104 4.8 (±0.74) × 104
3 0.155 (±0.11) 0.145 (±0.01) 0.156 (±0.16) 4.6 (±0.47) × 105 3.6 (±0.17) × 105 8.1 (±0.03) × 106
7 0.221 (±0.05) 0.232 (±0.15) 0.220 (±0.11) 5.2 (±0.36) × 105 7.5 (±0.48) × 105 2.3 (±0.33) × 105
Inside wall
TSB-Glu 1 0.465 (±0.18) 0.454 (±0.11) 0.460 (±0.11) 1.8 (±0.11) × 108 8.2 (±0.22) × 108 4.1 (±0.15) × 108
3 0.671 (±0.11) 0.667 (±0.12) 0.657 (±0.12) 8.6 (±0.23) × 109 3.6 (±0.36) × 109 3.5 (±0.22) × 1010
7 0.832 (±0.14) 0.844 (±0.04) 0.840 (±0.04) 6.2 (±0.49) × 109 4.2 (±0.15) × 1010 1.2 (±0.32) × 1010
Urine 1 0.243 (±0.09) 0.265 (±0.19) 0.255 (±0.19) 1.0 (±0.59) × 106 3.6 (±0.02) × 106 4.8 (±0.14) × 106
3 0.356 (±0.14) 0.347 (±0.04) 0.356 (±0.04) 6.3 (±0.47) × 107 8.3 (±0.06) × 108 2.8 (±0.21) × 108
7 0.447 (±0.17) 0.456 (±0.13) 0.464 (±0.13) 7.1 (±0.25) × 108 4.2 (±0.36) × 109 7.2 (±0.47) × 109
Plasma 1 0.108 (±0.14) 0.111 (±0.04) 0.122 (±0.04) 4.9 (±0.88) × 104 6.3 (±0.08) × 104 3.6 (±0.36) × 104
3 0.223 (±0.08) 0.211 (±0.18) 0.210 (±0.18) 3.2 (±0.92) × 105 1.5 (±0.63) × 104 2.8 (±0.15) × 105
7 0.299 (±0.20) 0.245 (±0.05) 0.285 (±0.05) 1.2 (±0.13) × 105 3.6 (±0.25) × 105 5.6 (±0.03) × 106
Notes: Biofilm biomass quantification and viable count of the biofilm cells of S. aureus grown in TSB-Glu, urine, and plasma on a catheter exposed to fluorine (0.5 mg/mL), and magnesium 
ions (0.5 mg/mL). Catheters incubated for 7 days at 37°C. Values in parentheses represent the standard deviation of three independent experiments conducted in triplicates.
Abbreviations: Glu, glucose; TSB, tryptic soy broth.
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